X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis
- PMID: 22919255
- PMCID: PMC3422803
- DOI: 10.3748/wjg.v18.i31.4207
X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis
Abstract
Aim: To perform a systematic meta-analysis to investigate the association between X-ray repair cross-complementing group 1 (XRCC1) polymorphisms and hepatocellular carcinoma (HCC) risk.
Methods: Relevant studies extracted from PubMed, Embase, Wanfang, VIP and the Chinese National Knowledge Infrastructure databases up to March 2012 were included in the study. Stata software, version 11.0, was used for the statistical analysis. The odds ratios (ORs) and 95% confidence interval (CI) of the XRCC1 polymorphisms in HCC patients were analyzed and compared with healthy controls. The meta-analysis was performed using fixed-effect or random-effect methods, depending on the absence or presence of significant heterogeneity.
Results: Eleven studies with 2075 HCC cases and 2604 controls met our eligibility criteria (four studies, 888 cases and 938 controls for Arg194Trp, four studies, 858 cases and 880 controls for Arg280His, and nine studies, 1845 cases and 2401 controls for Arg399Gln). The meta-analysis revealed no associations between the Arg194Trp and Arg399Gln polymorphisms of the XRCC1 gene and HCC risk under all contrast models (codominant, dominant and recessive models) in the overall analysis and sensitivity analysis (the studies with controls not in the Hardy-Weinberg equilibrium were excluded). For XRCC1 Arg280His polymorphism, the overall analysis revealed the significant association between the His/His genotype and the increased risk of HCC (His/His vs Arg/Arg model, OR: 1.96, 95% CI: 1.03-3.75, P = 0.04). However, sensitivity analysis showed an altered pattern of result and non-significant association (OR: 2.06, 95% CI: 0.67-6.25, P = 0.20). The heterogeneity hypothesis test did not reveal any heterogeneity, and Begg's and Egger's tests did not find any obvious publication bias.
Conclusion: The XRCC1 Arg194Trp and Arg399Gln polymorphisms are not associated with HCC risk. More rigorous association studies are needed to verify the involvement of XRCC1 Arg280His polymorphism in HCC susceptibility.
Keywords: Hepatocellular carcinoma; Meta-analysis; Polymorphism; X-ray repair cross-complementing group 1.
Similar articles
-
Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.Tumour Biol. 2013 Feb;34(1):261-9. doi: 10.1007/s13277-012-0546-5. Epub 2012 Oct 6. Tumour Biol. 2013. PMID: 23055199
-
Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.PLoS One. 2018 Nov 8;13(11):e0206853. doi: 10.1371/journal.pone.0206853. eCollection 2018. PLoS One. 2018. PMID: 30408066 Free PMC article.
-
Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.Tumour Biol. 2013 Oct;34(5):3265-9. doi: 10.1007/s13277-013-0899-4. Epub 2013 Jun 19. Tumour Biol. 2013. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 23780894 Retracted.
-
The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.Asian Pac J Cancer Prev. 2013;14(10):5761-7. doi: 10.7314/apjcp.2013.14.10.5761. Asian Pac J Cancer Prev. 2013. PMID: 24289575
-
XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.Liver Int. 2011 Jul;31(6):802-9. doi: 10.1111/j.1478-3231.2011.02508.x. Epub 2011 Mar 21. Liver Int. 2011. PMID: 21645210 Review.
Cited by
-
Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.Tumour Biol. 2013 Oct;34(5):2529-38. doi: 10.1007/s13277-013-0760-9. Epub 2013 Jul 16. Tumour Biol. 2013. PMID: 23857281
-
XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.Mol Biol Rep. 2014 Feb;41(2):879-87. doi: 10.1007/s11033-013-2929-0. Epub 2014 Jan 4. Mol Biol Rep. 2014. PMID: 24390232
-
Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.PLoS One. 2013;8(1):e55597. doi: 10.1371/journal.pone.0055597. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383237 Free PMC article.
-
XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.PLoS One. 2013 May 22;8(5):e64851. doi: 10.1371/journal.pone.0064851. Print 2013. PLoS One. 2013. PMID: 23717668 Free PMC article.
-
Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.PLoS One. 2013 Oct 29;8(10):e78071. doi: 10.1371/journal.pone.0078071. eCollection 2013. PLoS One. 2013. PMID: 24205095 Free PMC article.
References
-
- Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44 Suppl 19:96–101. - PubMed
-
- Sato K, Mori M. Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma. Curr Med Chem. 2011;18:4375–4388. - PubMed
-
- Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol. 2009;471:305–333. - PubMed
-
- Thompson LH, Bachinski LL, Stallings RL, Dolf G, Weber CA, Westerveld A, Siciliano MJ. Complementation of repair gene mutations on the hemizygous chromosome 9 in CHO: a third repair gene on human chromosome 19. Genomics. 1989;5:670–679. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous